(People's Daily Health Client Reporter Li Shuang) People's Daily Health Client Reporter found that on July 2, vitamin concept stocks continued to be active, Garden Biology rose by more than 10%, and Brother Technology, Guangji Pharmaceutical, Jindawei, Xinhua Pharmaceutical, etc. followed suit.
Since the beginning of this year, vitamin prices have shown a gradual upward trend. In addition to vitamin D3, which has attracted widespread attention, the price of multivitamins has also begun to rise. The People's Daily health client reporter learned from the Oriental Fortune Network that several pharmaceutical companies with outstanding performance on July 2 showed their unique advantages in the subdivision of the vitamin industry.
On July 2, the stock price trend of some pharmaceutical stocks. Oriental Fortune Network Map
Garden Bio: Focus on vitamin D3 products
Founded in 2000, the company focuses on the R&D, production and sales of vitamin D3 upstream and downstream products, as well as high-tech barrier preparation products in the field of cardiovascular and nervous system and other chronic diseases. According to its financial report, in the first quarter of 2024, the company achieved revenue of 330.3 million yuan, a year-on-year increase of 4.15%, and attributable net profit of 91.48 million yuan, a year-on-year increase of 76.41%, with obvious signs of recovery.
According to Garden Biology, the company has basically completed the layout of the whole vitamin D3 industry chain and has become a manufacturer of the whole vitamin D3 industry chain, with five categories of products: lanolin cholesterol, vitamin D3, 25-hydroxyvitamin D3, refined lanolin, and vitamin D3 environmentally friendly rodenticide.
Brother Technologies: A leading company in the field of vitamin K3 products
Founded in 1991, Brother Technology is a pharmaceutical and chemical company with vitamins as its main products, including vitamins B1, B3, B5 and K3, as well as chrome tanning agents and leather auxiliaries.
Brother Technology focuses on the fields of pharmaceuticals, foodstuffs and specialty chemicals, including vitamins, flavors and fragrances, pharmaceuticals and other related products, and has formed four major vitamin product platforms: vitamin K3, vitamin B1, vitamin B3 and vitamin B5. The company's vitamin product sales cover Europe, North America, Asia, etc., and the export business accounts for 54%. On June 27, Brother Technology said on the investor interactive platform that the company's vitamin products include vitamins B1, B3, B5, and K3, and there are currently no vitamin D products.
Guangji Pharmaceutical: One of the world's major suppliers of vitamin B2
According to public information, Guangji Pharmaceutical Co., Ltd. was founded in 1969, mainly producing vitamin B2, B6, B12, isovitamin C sodium, lactic acid and lactate series products, gluconic acid series products, starch series products and pharmaceutical preparation products, and is one of the world's major suppliers of vitamin B2 products.
At present, the company is mainly engaged in the research and development and production of vitamin raw material products, as well as the sales of raw materials and intermediates, and has three production bases in Wuxue, Mengzhou and Xianning, and has established a research and development center with raw materials and preparations as the core and a number of supporting subsidiaries, and has now developed into a modern pharmaceutical enterprise integrating research and development, production and sales.